Cargando…

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection

Detalles Bibliográficos
Autores principales:	Banck, Jan Christoph, Mueller, Niklas, Mellinghoff, Sibylle Christiane, Thelen, Martin, Fraccaroli, Alessia, Blumenberg, Viktoria, Koehler, Philipp, Kunz, Wolfgang Gerhard, Rudelius, Martina, Schrötzlmair, Florian, Subklewe, Marion, Schlößer, Hans Anton, Tischer, Johanna, Cornely, Oliver Andreas, Lindner, Lars Hartwin, von Bergwelt-Baildon, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886469/ https://www.ncbi.nlm.nih.gov/pubmed/33604513 http://dx.doi.org/10.1097/HS9.0000000000000530

Ejemplares similares

Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult
por: Sun, George, et al.
Publicado: (2023)

Der knochenmarktransplantierte Patient auf der Intensivstation
por: Stecher, S.-S., et al.
Publicado: (2021)

Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell therapy – a case report
por: Rejeski, Kai, et al.
Publicado: (2021)

Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient
por: Hu, Zhi-min, et al.
Publicado: (2021)

Invasive Aspergillosis in Patients Treated With Ibrutinib
por: Fürstenau, Moritz, et al.
Publicado: (2020)

2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn)
por: Salmanton-Garcia, Jon, et al.
Publicado: (2019)

372. Attributable Mortality of Candidemia After Introduction of Echinocandins
por: Cornely, Florian, et al.
Publicado: (2018)

Cerebro-rhino-orbital mucormycosis and aspergillosis coinfection in a patient with diabetes mellitus: A case report
por: Zayet, Souheil, et al.
Publicado: (2020)

Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment
por: Winkelmann, Michael, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival
por: Winkelmann, Michael, et al.
Publicado: (2022)

Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria
por: Winkelmann, Michael, et al.
Publicado: (2023)

Ten things the hematologist wants you to know about CAR-T cells
por: Böll, Boris, et al.
Publicado: (2020)

Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells
por: Karschnia, Philipp, et al.
Publicado: (2022)

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL
por: Rejeski, Kai, et al.
Publicado: (2022)

Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy
por: Winkelmann, Michael, et al.
Publicado: (2023)

Advances against Aspergillosis and Mucormycosis
por: Stevens, David A.
Publicado: (2020)

Dual Disseminated Aspergillosis and Mucormycosis Diagnosed at Autopsy: A Report of Two Cases of Coinfection and a Review of the Literature
por: Murray, Jason, et al.
Publicado: (2023)

Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies
por: Cordas dos Santos, David M., et al.
Publicado: (2022)

A fatal case report of invasive pulmonary aspergillosis and mucormycosis coinfection in an immunocompetent patient with coronavirus disease 2019 in Korea
por: Kim, Jin Hyoung, et al.
Publicado: (2023)

PTCY-Based Haploidentical Donor Transplantation versus HLA-Matched Related and Unrelated Donor Transplantations in Patients with Refractory or Relapsed Lymphoma—A Matched-Pair Analysis
por: Haebe, Sarah, et al.
Publicado: (2023)

Disseminated tuberculosis and gastric mucormycosis coinfection
por: Malek, Alexandre, et al.
Publicado: (2019)

SARS-CoV-2 vaccination in CLL: how often is enough?
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016)

Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia
por: Vučićević Boras, Vanja, et al.
Publicado: (2019)

COVID-19 associated with concomitant mucormycosis and aspergillosis
por: Lai, Chih-Cheng, et al.
Publicado: (2022)

Dexamethasone: Pulmonary aspergillosis and mucormycosis: case report
Publicado: (2021)

COVID-19 and Mucormycosis Coinfection: How Challenging It Is
por: Nayak, Niranjan, et al.
Publicado: (2022)

Influenza Coinfection: Be(a)ware of Invasive Aspergillosis
por: Verweij, Paul E, et al.
Publicado: (2020)

Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
por: Johnson, Andre K., et al.
Publicado: (2021)

Cytokine release syndrome
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2018)

COVID-19 Coinfection With Mucormycosis in a Diabetic Patient
por: R, Roopa, et al.
Publicado: (2021)

Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells
por: Karschnia, Philipp, et al.
Publicado: (2021)

Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy
por: Rejeski, Kai, et al.
Publicado: (2023)

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis – Authors' reply
por: Koehler, Philipp, et al.
Publicado: (2021)

The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
por: Ghosh, Asmita, et al.
Publicado: (2021)

Mucormycosis and Aspergillosis Infection Following Maxillofacial Trauma: Case Report
por: Sardeshmukh, Amruta Anil, et al.
Publicado: (2023)

Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment
por: Schoeberl, Florian, et al.
Publicado: (2022)

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
por: Rejeski, Kai, et al.
Publicado: (2022)

The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression
por: Rohrbacher, Lisa, et al.
Publicado: (2021)

Filamentous Fungi in Respiratory Infections. What Lies Beyond Aspergillosis and Mucormycosis?
por: Chowdhary, Anuradha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7rirah2g2vbv3u41viog8u23f9